Medicine & Life Sciences
Papillomavirus Vaccines
100%
Virus-Like Particle Vaccines
99%
Virion
76%
Vaccines
35%
human papillomavirus vaccine, L1 type 16, 18
27%
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
26%
Neoplasms
25%
Genotype
22%
Leukocyte L1 Antigen Complex
21%
B-Lymphocyte Epitopes
21%
Inactivated Vaccines
19%
DNA Vaccines
19%
T-Lymphocyte Epitopes
19%
Capsid
18%
Insecta
16%
Humoral Immunity
16%
Cellular Immunity
15%
Infections
15%
Developing Countries
14%
Yeasts
12%
Viruses
10%
Peptides
10%
Costs and Cost Analysis
9%
Safety
9%
Therapeutics
7%
Proteins
5%
Chemical Compounds
Epitope
81%
Oncogenic
55%
Safety
34%
Antigen
33%
Protective
33%